News (408)

Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update GL
Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease GL
Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 04:20 PM
Ultragenyx to Participate at Investor Conferences in March GL
Transcript : Ultragenyx Pharmaceutical Inc., Q4 2023 Earnings Call, Feb 15, 2024
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update GL
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update AQ
Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Heparan Sulfate Exposure in Cerebrospinal Fluid Correlated with Improved Long-term Cognitive Function in Patients with Sanfilippo Syndrome Type A (MPS IIIA) GL
Transcript : Ultragenyx Pharmaceutical Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM
Ultragenyx Reports Preliminary 2023 Revenue, Guidance for 2024 Revenue and Cash Usage, Pipeline Updates and 2024 Milestones AQ
Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones AQ
Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones GL
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference GL
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 10:00 AM
Ultragenyx to Participate at Investor Conferences in November GL
Ultragenyx to Participate at Investor Conferences in November AQ
Transcript : Ultragenyx Pharmaceutical Inc. Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-14-2023 12:30 PM
Ultragenyx to Participate in the Jefferies London Healthcare Conference GL
Ultragenyx to Participate in the Jefferies London Healthcare Conference AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q3 2023 Earnings Call, Nov 02, 2023
Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update GL
Transcript : Ultragenyx Pharmaceutical Inc. - Analyst/Investor Day
Ultragenyx Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease GL
Ultragenyx Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease AQ
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 08:50 AM
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Citi 18th Annual BioPharma Conference, Sep-06-2023 08:50 AM
Ultragenyx to Participate at Investor Conferences in September GL
Ultragenyx to Participate at Investor Conferences in September AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q2 2023 Earnings Call, Aug 03, 2023
Ultragenyx Reports Second Quarter 2023 Financial Results and Corporate Update GL
Ultragenyx Reports Second Quarter 2023 Financial Results and Corporate Update AQ
Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President, Corporate Strategy GL
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 03:20 PM
Ultragenyx to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference GL
Transcript : Ultragenyx Pharmaceutical Inc. - Special Call
Ultragenyx Pharmaceutical : Issues 2022 Environmental, Social and Governance (ESG) Report PU
Transcript : Ultragenyx Pharmaceutical Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 09:20 AM
Ultragenyx to Present at Bank of America’s 2023 Health Care Conference GL
Ultragenyx to Present at Bank of America’s 2023 Health Care Conference AQ
Transcript : Ultragenyx Pharmaceutical Inc., Q1 2023 Earnings Call, May 04, 2023
Ultragenyx Reports First Quarter 2023 Financial Results and Corporate Update GL
1234NextSee all

Companies (1)

FIYTA PRECISION TECHNOLOGY CO., LTD. 514 M $
Logo FIYTA Precision Technology Co., Ltd.

FIYTA Precision Technology Co., Ltd., formerly FIYTA HOLDINGS LTD., is a China-based company mainly engaged in the research and development, design, manufacture, sales and repairing of watches and the related parts and accessories. The Company's core busi ...


Insiders

Picture Emil Kakkis
Emil Kakkis

Emil D. Kakkis founded Ultragenyx Pharmaceutical, Inc. and Everylife Foundation for Rare Diseases. Dr. Kakkis occupies the position of President, Chief Executive Officer & Director at Ultragenyx Pharmaceutical, Inc. Dr. Kakkis is also on the board of Emil Kakkis & Jenny Soriano Living Trust and Odylia Therapeutics and President of Everylife Foundation for Rare Diseases. In his past career Dr. Kakkis was Chief Medical Officer & Senior Vice President for BioMarin Pharmaceutical, Inc. and Assistant Professor at Harbor-UCLA Medical Center. Dr. Kakkis received an undergraduate degree from Pomona College and a doctorate from David Geffen School of Medicine.


Picture Emil Brolick
Emil Brolick

Emil J.
Brolick
is currently a Member-Governors Board at Boys & Girls Clubs of America and an Operating Partner at Altamont Capital Management LLC.
Previously, he served as the Chief Executive Officer & Director at The Wendy's Co. from 2011 to 2018.
He was also the Vice Chairman at The Taco Bell Foundation, Inc. and held the position of Principal at Chrysler Corp.
Prior to that, he was the Chief Operating & Development Officer at Yum!.
Brands, Inc. from 2009 to 2010.
From 2008 to 2011, he served as the President at A&W Restaurants, Inc. and Long John Silver's LLC.
He was the President & Chief Concept Officer at Taco Bell Corp.
from 2000 to 2006.
Additionally, he held the position of Principal at Copeland Corp.
LLC and was a Trustee at Dave Thomas Foundation for Adoption.
He also worked as the Vice President-Marketing & Concept Development at Ponderosa, Inc. Mr. Brolick completed his undergraduate and graduate degrees at the University of Detroit Mercy.


Roland Emil Busch
Roland Emil Busch

Roland Emil Busch is a German businessperson who has been at the head of 6 different companies and presently occupies the position of President & Chief Executive Officer for Siemens AG and Chairman-Supervisory Board for Siemens WLL, Chairman-Supervisory Board for Siemens Mobility GmbH (Germany) and Chief Technology Officer for Siemens Ltd. China (which are all subsidiaries of Siemens AG). Roland Emil Busch is also Member-Management Board at Zentralverband Elektrotechnik- und Elektronikindustrie e.V. and Member-Management Board at Plattform Industrie 4.0 and on the board of 8 other companies. In his past career he was President & Chief Executive Officer at Siemens VDO Automotive Asia Pacific Co. Ltd., Chairman at Siemens Schweiz AG and Head-Strategy & Consulting at VDO Automotive AG. Dr. Busch received an undergraduate degree and a doctorate from Friedrich-Alexander University of Erlangen-Nuremberg, an undergraduate degree from the University of Grenoble and a doctorate and an undergraduate degree from Friedrich-Alexander-Universität Erlangen-Nürnberg.


Picture Harald Emil Wilhelm
Harald Emil Wilhelm

Mr. Harald E. Wilhelm is a Chief Financial Officer at Mercedes-Benz AG (Germany), a Chief Financial Officer at Daimler AG, a Chairman-Supervisory Board at Airbus Bank GmbH, a Chairman-Supervisory Board at Daimler Mobility AG and a Finance Director at European Aeronautic Defence & Space France SAS. He is on the Board of Directors at BAIC Motor Corp. Ltd. and Daimler Truck AG. Mr. Wilhelm was previously employed as a Co-Chief Executive Officer by Airbus Group SAS, a Chief Financial Officer by Airbus SE, a Chief Financial Officer by Airbus SAS, a Vice President-Mergers & Acquisitions by Airbus Defence & Space GmbH, a Vice President-Mergers & Acquisitions by DaimlerChrysler Aerospace AG, a Senior Manager-Mergers & Acquisitions by Daimler-Benz Aerospace AG, and a Member-Supervisory Board by Airbus Operations GmbH. He also served on the board at Airbus Defense & Space Holdings, Inc. He received his undergraduate degree from Ludwig-Maximilians-Universität München.


Picture Emil Ivaner
Emil Ivaner

Mr. Emil Ivaner is Chairman at International Transport SA.



Picture Emil Boldus
Emil Boldus

Emil Boldus served as the Chairman-Supervisory Board at Generali Asigurari SA.









Picture Emil Hajiyev
Emil Hajiyev

Emil Hajiyev worked as the Head-National Group at the Society for Worldwide Interbank Financial Telecommunication CV.




Picture Emil Eugen Pacurar
Emil Eugen Pacurar

Emil Eugen Pacurar currently works as a Systems Administrator at Magnetic Resonance Innovations, Inc.


Picture Emil Anderson
Emil Anderson

Emil Anderson has held positions as a Director at Nordic Capital Svenska AB and Itiviti Group AB.
He is currently a Partner at NC Advisory AB.


Picture Emil Nikolov
Emil Nikolov

Emil Nikolov is the founder of Nexcom - Bulgaria EAD, where he currently holds the title of Chairman.
Mr. Nikolov is also the founder of Nexcom Telecommunications LLC.




Picture Buck Bedard
Buck Bedard

Emil R.
Bedard
formerly worked at Mobilisa, Inc., as Director, Intellicheck, Inc., as Independent Director from 2008 to 2023, and United States Marine Corps, as Deputy Commandant-Plans, Policies & Operations.
Mr. Bedard received his graduate degree in 1967 from the University of North Dakota.



Picture Emil E. Ogden
Emil E. Ogden

Emil E.
Ogden
is a Co-Founder and a Director of Terrabon LLC and General Partner of Ogden-Chaparral Limited Partnership.
He co-founded Chaparral Minerals, Inc. in 1973 and served as Chief Executive Officer and President.
Mr. Ogden served in the United States Army Air Corps' "Brass Hat" Squadron.
He co-founded Chaparral Airlines, Inc. in 1976.
Mr. Ogden was a Member of the U.S.
State Department Foreign Investment Advisory Committee, the Governing Committee of the Texas Workers' Compensation Insurance Facility, the Texas A&M University Health Science Center Foundation, the George H.W.
Bush Presidential Library Director's Circle, Scott & White Hospital Foundation Board of Visitors, and the Board of Boys and Girls Clubs of Brazos Valley.
He received a BA degree in Philosophy from Texas A&M University in 1953.


Picture Emil Pot
Emil Pot

Emil Pot is the founder of Intrexon ActoBiotics NV, where he holds the title of Director-Business Development since 2006.
Mr. Pot is also the founder of Allero Therapeutics BV.
Mr. Pot's former job includes being a Principal at the University of Groningen and a Manager-Business Development at Vlaams Instituut voor Biotechnologie - Flanders Institute.
Mr. Pot's education includes graduating from the University of Groningen.



Picture Emil Davtyan
Emil Davtyan

Emil Davtyan worked as an Investment Manager at Wermuth Asset Management in Moscow.


Picture Emil Eli Khimji
Emil Eli Khimji

Mr. Emil E.
Khimji, CFA, is a Senior Analyst at RBC Global Asset Management, Inc. Mr. Khimji joined the PH&N Investment Management division of RBC GAM in November 2010 as a result of amalgamation between RBC Asset Management, Inc. and its affiliate, Phillips, Hager & North Investment Management Ltd.
(PH&N).
He joined PH&N in August 2007.
Mr. Khimji received his Bachelor of Commerce, Honors, in Finance from the University of British Columbia.


Picture Emil Rensing
Emil Rensing

Emil Rensing is the founder of Next New Networks, Inc. which was founded in 2007.
He is a former Director at BOLDFACE Group, Inc. from 2012 to 2013 and a former Chief Digital Officer at EPIX, Inc.







Picture Emil Mirica-Pufan
Emil Mirica-Pufan

Emil Mirica-Pufan worked as a Director at Severnav SA.




Picture Emil Alon
Emil Alon

Emil Alon founded Pebbles Ltd., where he worked as Chief Executive Officer and Resonai, Inc., where he worked as Chief Executive Officer.


Picture Emil Aaltonen
Emil Aaltonen

Emil Aaltonen worked as a Manager-Preclinical Development at Spago Nanomedical AB from 2015 to 2016.


Picture Emil Morariu
Emil Morariu

Emil Morariu worked as a Director at Mobex SA TG.
Mures from 2011 to 2022.
Prior to that, he obtained an undergraduate degree from Dunarea De Jos University of Galati in 1977.


Picture Emil Ivanov
Emil Ivanov

Emil Ivanov worked as a Group Director-Strategy & Planning at Permanent TSB Group Holdings Plc.


Picture Emil M. deGoma
Emil M. deGoma

Emil M.
deGoma
is a Member of Stanford University, American Heart Association, American College of Cardiology Foundation, and National Lipid Association.
He previously worked as Director-Medical Affairs at Cortria Corp.
and as Vice President-Clinical Development at Akebia Therapeutics, Inc. and Exicure, Inc. He received his undergraduate degree from Harvard University in 1997 and his doctorate degree from Harvard University in 2003.












Picture Emil Shalmiyev
Emil Shalmiyev

Emil Shalmiyev worked as an Analyst at JPMorgan Securities LLC from 2010 to 2017.
He also worked as an Analyst at JPMorgan Chase (Venture Capital) in 2010 and as an Assistant Trader at Aardvark Trading LLC in 2008.
Mr. Shalmiyev received his undergraduate degree from Carnegie Mellon University in 2009.




Picture Emil Beitpolous
Emil Beitpolous

Emil Beitpolous is currently the President of Solar United Network Inc. Prior to this, in 2014, he worked as a Director at Sunworks, Inc.


Picture Emil Eike
Emil Eike

Emil Eike is currently the Chairman at Bybanen AS.
He previously worked as the Commercial Director at Flytoget AS.
He obtained an MBA from BI Norwegian Business School in 2014.


Picture Emil Lee
Emil Lee

Emil Lee was the President of the Caribbean Hotel & Tourism Association.




Picture Emil Salim
Emil Salim

Emil Salim is currently the Vice Chairman of the National Planning Council.
He is also a Professor at the University of Indonesia.
Additionally, he serves as a Trustee for The Indonesian Biodiversity Foundation, a Member of the Indonesian Academy of Sciences, and a Member of the Brundtland Commission.
Dr. Salim previously held positions as the Deputy Chairman of the National Development Planning Agency, the Indonesia Ministry of Communication & Information, the Indonesia Ministry of Tourism, and the Indonesia Ministry of Transportation.
He also served as the Chairman of the Komite Ekonomi Nasional and as a Director for the Government of Indonesia.
Furthermore, he was a Member of the Institut Teknologi Bandung, the Indonesian Economists Association, the Aceh-Nias Rehabilitation & Reconstruction Agency, and the Komisi Nasional Hak Asasi Manusia.
He also held the position of Vice President Commissioner at PT Surya Semesta Internusa Tbk.
Dr. Salim obtained a doctorate degree from the University of California, Berkeley in 1964 and an undergraduate degree from the University of Indonesia in 1959.







Picture Emil Buric
Emil Buric

Emil Buric has worked as the Chairman-Supervisory Board at ZVVZ-Enven Engineering, a.s.
since 2016.



Picture Emil Peters
Emil Peters

Emil Peters currently works at Cerner France SAS, as Chairman from 2016, Cerner Ireland Ltd., as President & Director from 2017, and Cerner Health Services Deutschland GmbH, as Member-Supervisory Board.


Picture Emil Stawiarski
Emil Stawiarski

Emil Stawiarski has a current job as the Head of Sales & Accounts at InteliWISE SA.


Picture Emil Aberizk
Emil Aberizk

Emil Aberizk currently works as a Director at John Hancock Financial Network, Inc.


Picture Emil Ovemar
Emil Ovemar

Emil Ovemar is associated with Toca Boca AB as the founder and holds the title of Executive Producer since the company's founding in 2010.



Picture Emil Gafarov
Emil Gafarov

Emil Gafarov has worked as a Senior Manager at RMI Partners OOO since 2013.










Picture Emil Vainshel
Emil Vainshel

Emil Vainshel is currently the Vice Chairman at Ayalon Insurance Co. Ltd.
He is also the Chairman at WeSure Global Tech Ltd., WeSure Digital Insurance Services, Inc. (USA), and Managing Corporate of Compulsory Car Insurance (The Pool) Ltd.
In addition, he is a Director at U.
Digital Ltd., A.A Shy Holdings & Consulting (2010) Ltd., E.I.
Shay Holdings & Management Ltd., E.V.O.R Real Estate Ltd., WeSure Insurtech Services (India) Pvt Ltd., and a Member of the Institute of Certified Public Accountants (Israel).
Previously, he served as the Chief Executive Officer at Ayalon Insurance Co. Ltd., Chairman at Wesure Insurance Co. Ltd., Director-Customer & Distribution Channels at Migdal Insurance Co. Ltd., and Manager-Insurance Business at Harel Insurance Co. Ltd.
Mr. Vainshel holds an MBA from Tel-Aviv University and an undergraduate degree from Rhodes University.









Picture Emil Lawrence Harasym
Emil Lawrence Harasym

Mr. Lawrence Harasym is Chief Compliance Officer & Associate Counsel at JonesTrading Institutional Services LLC.
He joined JonesTrading in May 2006.
Previously, Mr. Harasym was Vice President, Director of Compliance with Imperial Capital, LLC.
Prior to this, he spent four years (2000-2004) with NASD as a Compliance Examiner.
From 1996 to 2000, he was the principal attorney of his own law firm in Westwood, CA, with an emphasis in transactional matters.
Mr. Harasym received his JD from the Thomas Jefferson School of Law in San Diego, CA and his BA from Loyola Marymount University.
He is admitted to practice law in California and has his Series 4, 7, 24, 53, 55, and 63 industry licenses.



Picture Emil Lee
Emil Lee

Emil Lee served as the Chief Agency Officer & Vice President at Manulife (International) Ltd.
from 2010 to 2011.
He obtained both undergraduate and graduate degrees from the University of Western Ontario.


Picture Emil Javier
Emil Javier

Emil Quinto Javier is currently the Chairman of The Asia Rice Foundation-Philippines, Nutrition Center of The Philippines, and Coalition For Agricultural Modernization of The Philippines.
He is also an Independent Non-Executive Director at Del Monte Pacific Ltd.
and an Independent Director at Centro Escolar University.
Additionally, he serves as a Director at the International Service for The Acquisition of Agri-Biotech App, Del Monte Philippines, Inc., Nutrition Foundation of The Philippines, Centro Escolar University Hospital, Inc., Del Monte Foods, Inc., and Las Piñas College.
Dr. Javier previously held positions as Chairman & President-Biology Division at the National Academy of Science Technology Philippines, Chairman at the International Rice Research Institute, Chairman at the Southeast Asian Regional Center For Graduate Study & Research, Director General at the Asian Vegetable Research Development Center, and President at the University of the Philippines.
He obtained a doctorate degree from Cornell University, an undergraduate degree from the University of the Philippines Los Baños, and a graduate degree from the University of Illinois At Urbana–Champaign.


Picture Emil Pahljna
Emil Pahljna

Emil Pahljna has worked as the Chief Executive Officer at Challenger Life CDI Nominees Pty Ltd since 2010.


Picture Emil E. Szot
Emil E. Szot

Emil E.
Szot
currently works at Townsquare Electric, Inc., as President.


Picture Emil Norton
Emil Norton

Emil Norton is currently the Vice Chairman at KOMAN, Inc. He previously worked as a Director at Natives of Kodiak, Inc.


Picture Emil Eskander
Emil Eskander

Emil Eskander worked as the Head of Economic Research at Bank of Alexandria SAE.


No results for this search